what is gip and glp-1 receptors The dual glucose-dependent insulinotropic polypeptide (GIP) glucagon-like peptide-1 (GLP-1) receptor agonist tirzepatide: a novel cardiometabolic therapeutic prospect | Cardiovascular Diabetology Targeting GLP-1, GIP & GCG

Dietary protein interventions to improve nutritional status in end-stage renal disease patients undergoing hemodialysis

We'll perform a comprehensive evaluation to determine if a GLP-1 program is the safest and most effective path for you

Individuals without recorded evidence of T2DM, including those without a diagnosis or evidence of first-line diabetes medication, were placed in the overweight or obesity group

Initially, cells were continuously treated with DTX at 1 IC until reaching 7080% confluence

Beverages Yerba Mate Market Yerba Mate Market Size, Share, and Growth Forecast, 2026 - 2033 Yerba Mate Market by Form (Powder, Loose Leaf, Liquid Concentrate), Application (Food & Beverages, Dietary Supplements, Cosmetics & Personal Care), Nature (Organic, Conventional), and Regional Analysis for 2026-2033 December 2025 215 Pages Author : Amol Patil Yerba Mate Market Share and Trends Analysis The global y erba mate market size is likely to be valued at US$ 2.1 billion in 2026 , and is projected to reach US$ 3.0 billion by 2033 , growing at a CAGR of 5.2% during the forecast period 20262033

Phase 2 = 29%